Literature DB >> 31872344

The direct oral anticoagulants may also be effective against the risk of post-thrombotic syndrome.

Gualtiero Palareti1, Benilde Cosmi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31872344     DOI： 10.1007/s11739-019-02251-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  17 in total

1.  Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome.

Authors:  C J J van Dongen; P Prandoni; M Frulla; A Marchiori; M H Prins; B A Hutten
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

Review 2.  Postthrombotic syndrome: a 2014 update.

Authors:  Jean-Philippe Galanaud; Susan R Kahn
Journal:  Curr Opin Cardiol       Date:  2014-11       Impact factor: 2.161

3.  Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.

Authors:  Y Whitney Cheung; Saskia Middeldorp; Martin H Prins; Akos F Pap; Anthonie W A Lensing; Arina J Ten Cate-Hoek; Sabina Villalta; Marta Milan; Jan Beyer-Westendorf; Peter Verhamme; Rupert M Bauersachs; Paolo Prandoni
Journal:  Thromb Haemost       Date:  2016-09-01       Impact factor: 5.249

4.  Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants.

Authors:  Paolo Prandoni; Walter Ageno; Nicola Mumoli; Nello Zanatta; Davide Imberti; Adriana Visonà; Maurizio Ciammaichella; Livio Simioni; Roberto Cappelli; Eugenio Bucherini; Marcello Di Nisio; Giampiero Avruscio; Giuseppe Camporese; Roberto Parisi; Stefano Cuppini; Giacomo Turatti; Franco Noventa; Lucia Sarolo
Journal:  Thromb Res       Date:  2017-03-27       Impact factor: 3.944

5.  Extended treatment of venous thromboembolism: a systematic review and network meta-analysis.

Authors:  Kang-Ling Wang; Nick van Es; Chris Cameron; Lana A Castellucci; Harry R Büller; Marc Carrier
Journal:  Heart       Date:  2018-10-16       Impact factor: 5.994

Review 6.  Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review.

Authors:  Russell D Hull; Jane Liang; Grace Townshend
Journal:  Am J Med       Date:  2011-08       Impact factor: 4.965

7.  The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.

Authors:  Menno V Huisman; Kenneth J Rothman; Miney Paquette; Christine Teutsch; Hans-Christoph Diener; Sergio J Dubner; Jonathan L Halperin; Chang Sheng Ma; Kristina Zint; Amelie Elsaesser; Dorothee B Bartels; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2017-02-21       Impact factor: 24.094

Review 8.  How I treat postthrombotic syndrome.

Authors:  Susan R Kahn
Journal:  Blood       Date:  2009-09-09       Impact factor: 22.113

9.  The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants.

Authors:  Paolo Prandoni; Walter Ageno; Maurizio Ciammaichella; Nicola Mumoli; Nello Zanatta; Davide Imberti; Adriana Visonà; Eugenio Bucherini; Marcello Di Nisio; Franco Noventa
Journal:  Intern Emerg Med       Date:  2019-10-30       Impact factor: 3.397

10.  Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism.

Authors:  Mette Søgaard; Peter Brønnum Nielsen; Flemming Skjøth; Jette Nordstrøm Kjældgaard; Craig I Coleman; Torben Bjerregaard Larsen
Journal:  Am J Med       Date:  2018-02-21       Impact factor: 4.965
View more
  1 in total

1.  The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position Paper.

Authors:  Benilde Cosmi; Agata Stanek; Matja Kozak; Paul W Wennberg; Raghu Kolluri; Marc Righini; Pavel Poredos; Michael Lichtenberg; Mariella Catalano; Sergio De Marchi; Katalin Farkas; Paolo Gresele; Peter Klein-Wegel; Gianfranco Lessiani; Peter Marschang; Zsolt Pecsvarady; Manlio Prior; Attila Puskas; Andrzej Szuba
Journal:  Front Cardiovasc Med       Date:  2022-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.